Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Naylor, GrahamG.
and
Smith, AnneH.W.
1982.
REDUCTION OF VANADATE, A POSSIBLE EXPLANATION OF THE EFFECT OF PHENOTHIAZINES IN MANIC-DEPRESSIVE PSYCHOSIS.
The Lancet,
Vol. 319,
Issue. 8268,
p.
395.
Esparon, J.
Kolloori, J.
Naylor, G. J.
McHarg, A. M.
Smith, A. H. W.
and
Hopwood, S. E.
1986.
Comparison of the Prophylactic Action of Flupenthixol with Placebo in Lithium Treated Manic-Depressive Patients.
British Journal of Psychiatry,
Vol. 148,
Issue. 6,
p.
723.
Silverstone, Trevor
and
Romans-Clarkson, Sarah
1989.
Bipolar Affective Disorder: Causes and Prevention of Relapse.
British Journal of Psychiatry,
Vol. 154,
Issue. 3,
p.
321.
Lowe, M. R.
and
Batchelor, D. H.
1990.
Lithium and neuroleptics in the management of manic depressive psychosis.
Human Psychopharmacology: Clinical and Experimental,
Vol. 5,
Issue. 3,
p.
267.
Silverstone, Trevor
1991.
Biological Aspects of Affective Disorders.
p.
271.
McKeon, Patrick
Manley, Patrick
and
Swanwick, Gregory
1992.
Manic-depressive illness — II: treatment outcome in bipolar disorder subtypes.
Irish Journal of Psychological Medicine,
Vol. 9,
Issue. 1,
p.
9.
Littlejohn, R.
Leslie, F.
and
Cookson, J.
1994.
Depot Antipsychotics in the Prophylaxis of Bipolar Affective Disorder.
British Journal of Psychiatry,
Vol. 165,
Issue. 6,
p.
827.
Hopkins, Heather S.
and
Gelenberg, Alan J.
1998.
The Practitioner’s Guide to Psychoactive Drugs.
p.
99.
CHOU, JAMES C.-Y.
SOLHKHAH, RAMON
and
SERPER, MARK
2000.
Clinical Research on Antipsychotics in Bipolar Disorder.
Journal of Psychiatric Practice,
Vol. 6,
Issue. 6,
p.
310.
Hellewell, Jonathan S. E.
2006.
A review of the evidence for the use of antipsychotics in the maintenance treatment of bipolar disorders.
Journal of Psychopharmacology,
Vol. 20,
Issue. 2_suppl,
p.
39.
Bond, D. J.
Pratoomsri, W.
and
Yatham, L. N.
2007.
Depot antipsychotic medications in bipolar disorder: a review of the literature.
Acta Psychiatrica Scandinavica,
Vol. 116,
Issue. s434,
p.
3.
Han, Changsu
Lee, Moon-Soo
Pae, Chi-Un
Ko, Young-Hoon
Patkar, Ashwin A.
and
Jung, In-Kwa
2007.
Usefulness of long-acting injectable risperidone during 12-month maintenance therapy of bipolar disorder.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 31,
Issue. 6,
p.
1219.
EL-MALLAKH, RIF S.
2007.
Medication Adherence and the Use of Long-Acting Antipsychotics in Bipolar Disorder.
Journal of Psychiatric Practice,
Vol. 13,
Issue. 2,
p.
79.
Fagiolini, Andrea
Casamassima, Francesco
Mostacciuolo, Wilmer
Forgione, Rocco
Goracci, Arianna
and
Goldstein, Benjamin I
2010.
Risperidone long-acting injection as monotherapy and adjunctive therapy in the maintenance treatment of bipolar I disorder.
Expert Opinion on Pharmacotherapy,
Vol. 11,
Issue. 10,
p.
1727.
Gigante, Alexandre Duarte
Lafer, Beny
and
Yatham, Lakshmi N.
2012.
Long-Acting Injectable Antipsychotics for the Maintenance Treatment of Bipolar Disorder.
CNS Drugs,
Vol. 26,
Issue. 5,
p.
403.
Boyce, Philip
Irwin, Lauren
Morris, Grace
Hamilton, Amber
Mulder, Roger
Malhi, Gin S
and
Porter, Richard J
2018.
Long‐acting injectable antipsychotics as maintenance treatments for bipolar disorder—A critical review of the evidence.
Bipolar Disorders,
Vol. 20,
Issue. S2,
p.
25.
Yıldızhan, Eren
Uzun, Eda
and
Tomruk, Nesrin Buket
2022.
Effect of long acting injectable antipsychotics on course and hospitalizations in bipolar disorder – a naturalistic mirror image study.
Nordic Journal of Psychiatry,
Vol. 76,
Issue. 1,
p.
37.
eLetters
No eLetters have been published for this article.